Elicera Therapeutics AB Capital Reinvestment Ratio

Latest as of December 2023: 0.00x

Elicera Therapeutics AB capital reinvestment ratio. Elicera Therapeutics AB (ELIC) has a Capital Reinvestment Ratio of 0.00x as of December 2023, meaning it reinvests 0% of its operating cash flow (Skr3.50 Million) in capital expenditures (Skr1.00K). Check ELIC capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.

Capital Reinvestment Ratio

0.00x

Capex / Operating Cash Flow

Operating Cash Flow

Skr3.50 Million

SEK

Capital Expenditures

Skr1.00K

SEK

Data as of

Dec 2023

Most recent filing

Elicera Therapeutics AB Capital Reinvestment Ratio by Year (None–None)

Elicera Therapeutics AB capital reinvestment ratio by year from None to None. For the full cash flow conversion analysis, see ELIC cash flow conversion.

Year	Reinvestment Ratio	Operating CF (SEK)	Capital Expenditures	YoY Change

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow